/Notis-Mcconarty Edward Increases Stake in Abbott Labs (ABT); Vista Capital Partners Has Lowered Stake in Intel (INTC) by $566,306 (via Qpute.com)
Abbott Laboratories (NYSE:ABT) Logo

Notis-Mcconarty Edward Increases Stake in Abbott Labs (ABT); Vista Capital Partners Has Lowered Stake in Intel (INTC) by $566,306 (via Qpute.com)


Abbott Laboratories (NYSE:ABT) Logo

Vista Capital Partners Inc decreased its stake in Intel Corp (INTC) by 39.11% based on its latest 2018Q4 regulatory filing with the SEC. Vista Capital Partners Inc sold 12,311 shares as the company’s stock rose 10.40% with the market. The institutional investor held 19,169 shares of the semiconductors company at the end of 2018Q4, valued at $899,000, down from 31,480 at the end of the previous reported quarter. Vista Capital Partners Inc who had been investing in Intel Corp for a number of months, seems to be less bullish one the $228.51 billion market cap company. The stock decreased 0.14% or $0.07 during the last trading session, reaching $51.04. About 21.15 million shares traded. Intel Corporation (NASDAQ:INTC) has risen 12.75% since May 1, 2018 and is uptrending. It has outperformed by 8.38% the S&P500. Some Historical INTC News: 19/03/2018 – INTEL CORP – RISA LAVIZZO-MOUREY HAS BEEN ELECTED TO INTEL’S BOARD OF DIRECTORS; 17/05/2018 – Intel Corporation’s (INTC) CEO Brian Krzanich Hosts 2018 Stockholders’ Meeting (Transcript); 08/05/2018 – Intel Exec Says Companies Need to Better Retain Diverse Talent (Video); 26/04/2018 – Intel raises full-year forecasts on demand for data center chips; 12/04/2018 – Accenture Appoints Venkata “Murthy” Renduchintala, Executive Officer at Intel, to Board of Directors; 27/04/2018 – Four U.S. tech companies — Amazon, Microsoft, Intel and Google — were among the top 10 employers for approved H-1B applications in FY 2017, according to a new study; 21/05/2018 – Intel Puts Its Own Spin on Quantum Computing — Barron’s Blog; 07/05/2018 – AVer’s Video Collaboration Technology Delivers Ultimate Huddle Room Experience Using Intel Unite® Solution; 05/03/2018 – McAfee Recognized on CRN’s 2018 Security 100 List; 06/03/2018 – DoD: Intel Chiefs Tell Senate Committee of Dangers to America

Notis-Mcconarty Edward increased its stake in Abbott Labs (ABT) by 4.75% based on its latest 2018Q4 regulatory filing with the SEC. Notis-Mcconarty Edward bought 4,360 shares as the company’s stock rose 7.95% with the market. The institutional investor held 96,060 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $6.95M, up from 91,700 at the end of the previous reported quarter. Notis-Mcconarty Edward who had been investing in Abbott Labs for a number of months, seems to be bullish on the $139.75 billion market cap company. The stock increased 1.65% or $1.29 during the last trading session, reaching $79.56. About 5.51M shares traded. Abbott Laboratories (NYSE:ABT) has risen 33.73% since May 1, 2018 and is uptrending. It has outperformed by 29.36% the S&P500. Some Historical ABT News: 11/04/2018 – Abbott: Trial Will Assess if Stent Procedures Guided by High-Resolution Imaging Result in Larger Vessel Diameters and Improved Patient Clinical Outcomes; 10/04/2018 – Abbott says NAFTA “had to be updated” due to technology and intellectual property challenges; 29/03/2018 – Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor; 02/04/2018 – FTC: FTC Acting Chairman Ohlhausen Appoints Alden Abbott as Acting General Counsel; 18/04/2018 – ABBOTT LABORATORIES – QTRLY TOTAL NUTRITION SALES $ 1,756 MLN VS $1,642 MLN REPORTED LAST YEAR; 29/03/2018 – Cardiovascular: Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor; 07/03/2018 – Abbott’s Confirm Rx connects an insertable cardiac monitor to a smartphone app; 19/03/2018 – ABBOTT LABORATORIES – MITRACLIP SYSTEM IS APPROVED IN JAPAN FOR TREATMENT OF BOTH SEVERE DEGENERATIVE MITRAL REGURGITATION AND FMR HEART DISEASES; 03/05/2018 – ABBOTT EXPANDS CARDIAC ARRHYTHMIAS PORTFOLIO W/ FDA CLEARANCE; 11/03/2018 – ABBOTT SAYS HEARTMATE 3 STUDY MET PRIMARY ENDPOINT AT TWO YEARS

Since November 29, 2018, it had 2 insider buys, and 7 insider sales for $495,361 activity. 710 Intel Corporation (NASDAQ:INTC) shares with value of $33,256 were sold by Shenoy Navin.

More notable recent Intel Corporation (NASDAQ:INTC) news were published by: Nasdaq.com which released: “5 Top Stock Trades for Thursday: Ford, AT&T, iRobot – Nasdaq” on April 24, 2019, also Nasdaq.com with their article: “Pre-Market Most Active for Apr 26, 2019 : F, AMD, SQQQ, PETX, CHK, INTC, IQ, XOM, TAL, ACB, MU, TS – Nasdaq” published on April 26, 2019, Seekingalpha.com published: “Intel Earnings Are Not What They Seem To Be – Seeking Alpha” on April 29, 2019. More interesting news about Intel Corporation (NASDAQ:INTC) were released by: Seekingalpha.com and their article: “In Case Intel’s Share Price Collapses – Seeking Alpha” published on April 07, 2019 as well as Nasdaq.com‘s news article titled: “Noteworthy ETF Inflows: QQQ, INTC, ADP, INTU – Nasdaq” with publication date: April 24, 2019.

Investors sentiment increased to 1 in Q4 2018. Its up 0.15, from 0.85 in 2018Q3. It is positive, as 52 investors sold INTC shares while 677 reduced holdings. 141 funds opened positions while 588 raised stakes. 2.96 billion shares or 3.57% more from 2.86 billion shares in 2018Q3 were reported. Yhb Advisors holds 0.38% or 45,694 shares. Retirement Of Alabama holds 0.86% or 3.33M shares in its portfolio. Bluefin Trading Ltd Liability Company holds 0.76% or 160,076 shares. Union Bank Corp reported 1.8% in Intel Corporation (NASDAQ:INTC). Paradigm Fincl Advsrs Lc accumulated 2.25% or 107,263 shares. Delphi Mgmt Ma stated it has 43,886 shares. De Burlo Grp Incorporated stated it has 118,691 shares or 1.25% of all its holdings. D L Carlson Investment Gp has 1.97% invested in Intel Corporation (NASDAQ:INTC) for 126,611 shares. Semper Augustus Invs Grp Inc Limited reported 0.62% in Intel Corporation (NASDAQ:INTC). 705,455 were reported by Shelton Cap. Private Harbour Inv Mngmt And Counsel Ltd Liability Company holds 12,400 shares or 0.64% of its portfolio. Great West Life Assurance Com Can holds 0.7% of its portfolio in Intel Corporation (NASDAQ:INTC) for 5.22 million shares. Linscomb And Williams accumulated 0.59% or 133,882 shares. Twin Cap Mgmt Inc holds 1.24% of its portfolio in Intel Corporation (NASDAQ:INTC) for 467,665 shares. Roundview reported 19,355 shares or 0.25% of all its holdings.

Investors sentiment decreased to 0.91 in 2018 Q4. Its down 0.05, from 0.96 in 2018Q3. It dived, as 61 investors sold ABT shares while 576 reduced holdings. 143 funds opened positions while 434 raised stakes. 1.29 billion shares or 4.79% more from 1.23 billion shares in 2018Q3 were reported. The Nebraska-based Nelson Van Denburg & Campbell Wealth Group Limited Liability Com has invested 0.07% in Abbott Laboratories (NYSE:ABT). Conning accumulated 44,627 shares or 0.11% of the stock. Atria Invests Ltd Liability Corporation reported 65,449 shares stake. North Point Managers Corp Oh reported 209,319 shares or 3.34% of all its holdings. Private Ocean Ltd Co invested 0.04% of its portfolio in Abbott Laboratories (NYSE:ABT). Fred Alger Mgmt owns 4.80 million shares or 1.6% of their US portfolio. Eubel Brady And Suttman Asset Management accumulated 7,178 shares. Dorsey Wright & Associate, California-based fund reported 23,037 shares. Town & Country Comml Bank & Dba First Bankers reported 100,082 shares or 1.88% of all its holdings. Invest Mgmt Of Virginia has 2.22% invested in Abbott Laboratories (NYSE:ABT) for 118,234 shares. Johnson Invest Counsel holds 1.95% in Abbott Laboratories (NYSE:ABT) or 1.11 million shares. Vanguard Grp owns 144.26 million shares. New Vernon Ltd owns 1.24% invested in Abbott Laboratories (NYSE:ABT) for 5,918 shares. Destination Wealth Management reported 256,823 shares. Cls Investments Lc holds 0% or 140 shares in its portfolio.

More notable recent Abbott Laboratories (NYSE:ABT) news were published by: Seekingalpha.com which released: “Abbott Laboratories Q1 2019 Earnings Preview – Seeking Alpha” on April 16, 2019, also Fool.com with their article: “3 Dividend Aristocrats to Buy and Hold Forever – The Motley Fool” published on April 26, 2019, Seekingalpha.com published: “Abbott Laboratories EPS in-line, beats on revenue – Seeking Alpha” on October 17, 2018. More interesting news about Abbott Laboratories (NYSE:ABT) were released by: Fool.com and their article: “20 High-Growth Stocks for the Next 20 Years – Motley Fool” published on April 29, 2019 as well as Forbes.com‘s news article titled: “What To Expect From Abbott In Q1? – Forbes” with publication date: April 16, 2019.

Intel Corporation (NASDAQ:INTC) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.


This is a syndicated post. Read the original post at Source link .